YourEra review
Both advertised figures need six months, and no month-to-month rate is published for either.
The verdict
YourEra advertises from $79.20 a month for compounded semaglutide, and its own page states that figure reflects the six-month plan. Tirzepatide reads as low as $159.20 on the same plan, and neither month-to-month rate is published.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- Not published by the provider
YourEra sells both molecules by injection at the same price at every dose, with a six-month plan behind the advertised figure and a separate month-to-month path.
Who writes the prescription, and what do they see?
A prescription precedes shipping and the clinician is not described. What the pages do describe carefully is which figure belongs to which plan, at least on the semaglutide line.
The semaglutide disclosure is good: the six-month condition is written out in a sentence rather than hidden in an asterisk. The tirzepatide card labels its figure the same way. What neither discloses is the rate a buyer pays month to month.
What happens when the dose goes up?
Same price at every dose is confirmed on the semaglutide line, so escalation does not move that figure. On tirzepatide the pages say nothing about dose, and the prior question is what the line costs off the six-month plan.
What the price includes
Six months of semaglutide at $79.20 is $475.20, and tirzepatide at $159.20 is $955.20, each paid on the plan the figure belongs to. The month-to-month rate on either line is higher and not published, so a reader who wants to stop early has no figure to plan against.
What it claims, and what it cites
Both lines are compounded rather than manufactured, prepared by a pharmacy the site does not name, and not reviewed by the FDA before dispensing as an approved product is.
Where it holds up, and where it does not
- Strength: The six-month condition is stated in a sentence
- Strength: Same price at every dose on semaglutide
- Strength: Both cards name the plan behind the figure
- Limitation: The advertised figure needs six months
- Limitation: No month-to-month rate is published
- Limitation: Tirzepatide also needs six months
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about YourEra. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader committing six months who has read which figure belongs to which plan.
- Wrong for
- A reader who wants to pay month to month, since no rate for it is published.
The evidence behind what YourEra prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How YourEra compares
| Seller | Who it suits | Go |
|---|---|---|
 Wellorithm | Readers who will read the checkout catalog rather than the landing page | See Wellorithm → |
 Woodwork | Readers ready to commit forty-eight weeks who read asterisks | See Woodwork → |
 YourHealthRx | Readers in any jurisdiction wanting a flat rate with little to decide | See YourHealthRx → |
More GLP-1 telehealth sellers reviews: LivbetrLongevity MedsLoozyMale ExcelMangoRxMD Trim Clinic
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Can I pay $79.20 a month?
- Only on the six-month plan, which the page states in so many words. The month-to-month rate is higher and not published.
- What does tirzepatide cost?
- As low as $159.20 a month on the six-month plan, the label printed on its own card. No month-to-month rate is published.
- Does the price rise with the dose?
- Not on semaglutide — the same price at every dose is confirmed on that line.